Investors


Pyng Medical is Award-Winning Medical Device Technology

Pyng Medical Corp. (PYT:TSX.V) engineers and markets award-winning trauma and resuscitation products for front-line critical care personnel world-wide.

Pyng’s product portfolio includes innovative sternal intraosseous (sternal IO) pelvic stabilization and tourniquet devices specifically designed and customized for both the military and civilian markets. With growing markets in North America, Europe and Asia, Pyng develops user-preferred medical devices for use by hospital staff, emergency medical services and military forces worldwide.

A Pioneer in Sternal Intraosseous Infusion Technology:

Pyng Medical is the pioneer in sternal intraosseous infusion technology. FAST1 was first cleared for Adults in 1997 and was available in 2000. In April 2008, FAST1 was cleared for use in adolecents.

FAST1 has been trusted and used by military and EMSpersonnel for more than 12 years. In fact, more combat personnel use FAST1 sternal IO than any other sternal or tibial IO device.

In 2013, Pyng launched FASTCombat and FASTResponder, which include all the trusted and proven features of FAST1, but modified to specifically meet the needs of civilian emergency medical services and hospital critical care personnel.

Award-Winning Medical Device Technology:

Pyng’s MAT® Tourniquet was recognized in 2009 as one of the “ten top products that changed the world” by Wired for Design, and has received rewards including the IDSA’s Gold Award for Best Medical Product Design of 2006 and 2007, Design of a Decade in 2010 (Silver), and 2007 INDEX Award for best medical product in the world (Finalist).

Pyng also received the exclusive 2008 Medical Device Company of the Year Award from LifeSciences British Columbia for our sustained achievements in commercializing FAST1®, the first medical device that offers the advantages of rapid sternal access for administering drugs and fluids to the heart. Pyng was also honored with a Gold 2000 Medical Design Excellence Award for its FAST1™ Intraosseous Infusion System. Recognized in the Critical-Care and Emergency Medicine Products category, FAST1™ was singled-out for its ease-of-use, effectiveness, and rapid sternal delivery of critical fluids and medications to patients for whom IV is difficult or impossible.

Additionally, Pyng Medical was selected for inclusion in the 2007 TSX Venture 50 “Top 10 Companies in Life Sciences” list, based on financial metrics for 2006.

Investor Quick Links:

Financials:

Pyng Medical Corp. annual and quarterly financial reports are filed online with SEDAR (System for Electronic Document Analysis and Retrieval).

Fiscal 2016 Third Quarter

Financial Statement and Notes as of June 30th 2016
Management Discussion and Analysis as of June 30th 2016

Fiscal 2016 Second Quarter

Financial Statement and Note as of March 31st 2016
Management Discussion and Analysis as of March 31st 2016

Fiscal 2016 First Quarter

Financial Statement and Notes as of December 31st 2015
Management Discussion and Analysis as of December 31st 2015

Fiscal 2015 Fourth Quarter

Financial Statement and Notes as of September 30th, 2015
Management Discussion and Analysis as of September 30th 2015

Fiscal 2015 Third Quarter

Financial Statement and Notes as of June 30th, 2015
Management Discussion and Analysis as of June 30th, 2015

Fiscal 2015 Second Quarter

Financial Statement and Notes as of March 31st, 2015
Management Discussion and Analysis as of March 31st, 2015

Fiscal 2015 First Quarter

Financial Statement and Notes as of December 31, 2014
Management Discussion and Analysis as of December 31, 2014

Fiscal 2014 Fourth Quarter

Financial Statement and Notes as of September 30, 2014
Management Discussion and Analysis as of September 30, 2014

Fiscal 2014 Third Quarter

Financial Statement and Notes as of June 30, 2014
Management Discussion and Analysis as of June 30, 2014

Fiscal 2014 Second Quarter
Financial Statement and Notes as of March 31, 2014
Management Discussion and Analysis as of March 31, 2014

Fiscal 2014 First Quarter
Financial Statement and Notes as of December 31, 2013
Management Discussion and Analysis as of December 31, 2013

Fiscal 2013 Annual Reports
Financial Statement and Notes as of September 30, 2013
Management Discussion and Analysis as of September 30, 2013

Fiscal 2013 Third Quarter
Financial Statement and Notes as of June 30, 2013
Management Discussion and Analysis as of June 30, 2013

Fiscal 2013 Second Quarter
Financial Statement and Notes as of March 31, 2013
Management Discussion and Analysis as of March 31, 2013

Fiscal 2013 First Quarter
Financial Statement and Notes as of December 31, 2012
Management Discussion and Analysis as of December 31, 2012

Fiscal 2012 Annual Reports
Financial Statement and Notes as of September 30, 2012
Management Discussion and Analysis as of September 30, 2012

Fiscal 2012 Third Quarter
Financial Statement and Notes as of June 30, 2012
Management Discussion and Analysis as of June 30, 2012

Fiscal 2012 Second Quarter
Financial Statement and Notes as of March 31, 2012

Management Discussion and Analysis as of March 31, 2012

Fiscal 2012 First Quarter
Financial Statement and Notes as of December 31, 2011
Management Discussion and Analysis as of December 31, 2011

Fiscal 2011 Annual Reports
Financial Statement and Notes as of September 30, 2011
Managment Discussion and Analysis as of September 30, 2011

Fiscal 2011 Third Quarter
Financial Statement and Notes as of June 30, 2011
Managment Discussion and Analysis as of June 30, 2011

Fiscal 2011 Second Quarter
Financial Statement and Notes as of March 31, 2011
Managment Discussion and Analysis as of March 31, 2011

Fiscal 2011 First Quarter
Financial Statement and Notes as of December 31, 2010
Managment Discussion and Analysis as of December 31, 2010

Fiscal 2010 Annual Reports
Financial Statements and Notes as of September 30, 2010
Management Discussion and Analysis as September 30, 2010

Fiscal 2010 First Quarter
Financial Statements and Notes as of December 31, 2009
Management Discussion and Analysis as of December 31, 2009

Fiscal 2009 Annual Reports
Financial Statements and Notes as of September 30, 2009
Management Discussion and Analysis as of September 30, 2009

Fiscal 2009 Third Quarter
Financial Statements and Notes as of June 30, 2009
Management Discussion and Analysis as of June 30, 2009

Fiscal 2009 Second Quarter
Financial Statements and Notes as of March 31, 2009
Management Discussion and Analysis as of March 31, 2009

Fiscal 2009 First Quarter

Financial Statements and Notes as of December 31, 2008
Management Discussion and Analysis as of December 31, 2008

Fiscal 2008 Annual Reports

Financial Statements and Notes as of September 30, 2008
Management Discussion and Analysis as of September 30, 2008

Fiscal 2008 Third Quarter Results
Financial Statements and Notes as of June 30, 2008
Management Discussion and Analysis as of June 30, 2008

Fiscal 2008 Second Quarter
Financial Statements and Notes as of March 31, 2008
Management Discussion and Analysis as of March 31, 2008

Fiscal 2008 First Quarter
Financial Statements and Notes as of December 31, 2007
Management Discussion and Analysis as of December 31, 2007

Fiscal 2007 Annual Reports
Financial Statements and Notes as of September 30, 2007
Management Discussion and Analysis as of September 30, 2007

Agents

  • Transfer agent: Computershare Investor Services Inc., Vancouver, BC
  • Auditors: Morgan LLP, Vancouver, BC
  • Legal counsel: Blake Cassels & Graydon , Vancouver, BC

Analyst Coverage:

Northern Securities Inc.
604.668.1932

Pyng Medical Corp. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Pyng Medical’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Pyng Medical or its management. Pyng Medical does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Research Reports:

View the Research Report from Advanced Investor Intelligence on Pyng Medical Corp. here.

Corporate Governance:

Pyng Medical Corporation is managed under the direction of the Board of Directors, whose purpose is to maximize long-term economic value for our shareholders by responsibly addressing the concerns of our employees, business partners, communities, and government. Pyng has adopted corporate governance practices to promote the effective functioning of the Board, its committees and the company. All employees, officers and directors are required to adhere to principals of integrity and honesty while conducting business on behalf of Pyng Medical Corporation.




Latest Financial News Releases:

Our Vision

Pyng Medical will play a critical role in helping First Responders and First Receivers save the lives of every person that can be saved in an emergency or trauma situation.

Learn More

Our Mission

We Listen. We Imagine. We Help.

Pyng Medical will listen to the concerns of First Responders and First Receivers, will imagine solutions that would help them and their patients, and will bring to market life-saving medical devices, when seconds count in improving patient outcomes.

Learn More

Information Request

Please complete the following form for questions, comments or information requests.

Your Name (required)

Your Email (required)

Subject

Your Message